• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by GE HealthCare Technologies Inc. (Amendment)

    4/2/24 4:07:29 PM ET
    $GEHC
    Medical Electronics
    Health Care
    Get the next $GEHC alert in real time by email
    SC 13G/A 1 eh240459869_13ga2-gehc.htm AMENDMENT NO. 2

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

    (Amendment No. 2)*

     
    GE HEALTHCARE TECHNOLOGIES INC.
    (Name of Issuer)
     
    Common Stock, $0.01 par value
    (Title of Class of Securities)
     
    36266G 107
    (CUSIP Number)
     
    March 31, 2024
    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

      ☐ Rule 13d-1(b)
      ☐ Rule 13d-1(c)
      ☒ Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

       

     

     

    CUSIP No. 36266G 107 SCHEDULE 13G Page 2 of 6

     

     

    1

    NAME OF REPORTING PERSON

     

    General Electric Company

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a)  ☐

    (b)  ☐

    3

    SEC USE ONLY

     

     

     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    New York

     

    NUMBER OF

    SHARES

    BENEFICIALLY OWNED

    BY EACH REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    30,531,302 (See Note 1)

    6

    SHARED VOTING POWER

     

    0

    7

    SOLE DISPOSITIVE POWER

     

    30,531,302 (See Note 1)

    8

    SHARED DISPOSITIVE POWER

     

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    30,531,302 (See Note 1)

     
    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    6.7% (See Note 2)

     
    12

    TYPE OF REPORTING PERSON

     

    CO

     

     

    Note 1: As of March 31, 2024, General Electric Company (“GE”) beneficially owned 30,531,302, or approximately 6.7%, of the shares of common stock (“Common Stock”) outstanding of GE HealthCare Technologies Inc. (the “Company”). Pursuant to a Stockholder and Registration Rights Agreement, dated as of January 2, 2023 (the “Stockholder and Registration Rights Agreement”), between GE and the Company, GE granted to the Company a proxy to vote the shares of Common Stock owned by GE in proportion to the votes cast by the Company’s other stockholders.

     

    Note 2: The denominator for this calculation is based on 455,357,229 shares of Common Stock outstanding as of January 30, 2024, as reported in the Company’s Form 10-K filed with the U.S. Securities and Exchange Commission on February 6, 2024.

     

       

     

     

    CUSIP No. 36266G 107 SCHEDULE 13G Page 3 of 6

     

     

    Item 1. (a) Name of Issuer:
         
        GE HealthCare Technologies Inc.
         
      (b) Address of Issuer’s Principal Executive Offices:
         
        500 W. Monroe Street, Chicago, Illinois 60661
       
    Item 2. (a) Name of Person Filing:
         
        General Electric Company
         
      (b) Address of Principal Business Office, or if none, Residence:
         
        One Financial Center, Suite 3700, Boston, Massachusetts 02111
         
      (c) Citizenship:
         
        New York
         
      (d) Title of Class of Securities:
         
        Common Stock, $0.01 par value
         
      (e) CUSIP Number:
         
        36266G 107
         
    Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
         
      (a) [__] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o);
      (b) [__] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);
      (c) [__] Insurance Company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);
      (d) [__] Investment Company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
      (e) [__] An investment adviser in accordance with Rule 240.13d-1(b)(1)(ii)(E);
      (f) [__] An employee benefit plan or endowment fund in accordance with Rule 240.13d-1(b)(1)(ii)(F);
      (g) [__] A parent holding company or control person in accordance with Rule 240.13d-1(b)(1)(ii)(G);
      (h) [__] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
      (i) [__] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); or
      (j) [__] Group, in accordance with §240.13d-1(b)(1)(ii)(K).
          If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: ___________________________.
      (k) [__] A group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:  ___________________________.

     

     

       

     

     

    CUSIP No. 36266G 107 SCHEDULE 13G Page 4 of 6

     

     

    Item 4. Ownership.
       
     

    (a)-(c)

     

    The responses of the Reporting Person to Rows 5, 6, 7, 8, 9 and 11 in the cover page to this Section 13G are incorporated herein by reference.

     

    Additional Note: Pursuant to the Stockholder and Registration Rights Agreement, GE granted to the Company a proxy to vote the shares of Common Stock owned by GE in proportion to the votes cast by the Company’s other stockholders.

     

    Item 5. Ownership of Five Percent or Less of a Class.
       
      Not applicable.
       
    Item 6. Ownership of More than Five Percent on Behalf of Another Person.
       
      Not applicable.
       
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
       
      Not applicable.

     

     

       

     

     

    CUSIP No. 36266G 107 SCHEDULE 13G Page 5 of 6

     

     

    Item 8. Identification and Classification of Members of the Group.
       
      Not applicable.
       
    Item 9. Notice of Dissolution of Group.
       
      Not applicable.
       
    Item 10. Certifications.
       
      Not applicable.

     

     

     

     

     

       

     

     

    CUSIP No. 36266G 107 SCHEDULE 13G Page 6 of 6

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: April 2, 2024

     

      GENERAL ELECTRIC COMPANY  
           
           
      By: /s/ Brandon Smith  
        Name: Brandon Smith  
        Title: Chief Corporate, Securities & Finance Counsel  

     

     

     

     

       

     

     

    Get the next $GEHC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GEHC

    DatePrice TargetRatingAnalyst
    5/5/2025$73.00Sell → Neutral
    UBS
    3/11/2025$85.00 → $100.00Neutral → Buy
    Goldman
    1/8/2025$95.00 → $103.00Hold → Buy
    Jefferies
    9/26/2024$84.00 → $74.00Neutral → Sell
    UBS
    9/18/2024$100.00Neutral → Buy
    BTIG Research
    9/9/2024$90.00Neutral
    JP Morgan
    8/6/2024$100.00Buy
    Stifel
    5/30/2024$87.00Neutral
    Goldman
    More analyst ratings

    $GEHC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • AI Healthcare Boom Gains Speed as Regulators and Innovators Align

      Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, May 5, 2025 /PRNewswire/ --The integration of artificial intelligence (AI) into healthcare is here to stay, and adoption is accelerating. According to research from PYMNTS Intelligence which polled C-suite executives at healthcare companies generating at least $1 billion in annual revenue, 90% already see positive ROI from investments in generative AI (GenAI). Analysts are projecting that by 2035 the gross value added by AI to the healthcare industry will be $461 billion on top of a baseline $2.26 trillion. Behind the scenes, several new AI healthcare tech developments are taking place, with updates rec

      5/5/25 12:35:00 PM ET
      $GEHC
      $SDGR
      $TEM
      $TVGN
      Medical Electronics
      Health Care
      Biotechnology: Pharmaceutical Preparations
      Computer Software: Programming Data Processing
    • ESTRO 2025 Congress: GE HealthCare to expand its radiation oncology portfolio and introduce new AI-enabled solutions

      The company will showcase innovations designed to optimize the oncology care workflow and enable improved patient outcomes GE HealthCare (NASDAQ:GEHC) today announced an intended expansion of its radiation oncology portfolio as well as the introduction of the new AI-enabled MR Contour DL™ at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2025 Congress in Vienna, Austria. The company will also showcase its updated Intelligent Radiation Therapy (iRT), a software solution that standardizes complex workflows, helping to enable a shorter timeline from diagnosis to treatment and more precise radiation therapy. According to the World Health Organization (WHO), cancer conti

      5/2/25 9:00:00 AM ET
      $GEHC
      Medical Electronics
      Health Care
    • GE HealthCare reports first quarter 2025 financial results

      Revenue growth was 3% year-over-year; Organic revenue growth* was 4% Net income margin was 11.8% versus 8.0% for the prior year; Adjusted earnings before interest and taxes (EBIT) margin* was 15.0% versus 14.7% Diluted earnings per share (EPS) were $1.23 versus $0.81 for the prior year; Adjusted EPS* was $1.01 versus $0.90 Cash flow from operating activities was $250 million versus $419 million for the prior year; Free cash flow* was $98 million versus $274 million Updates full-year 2025 guidance Board of Directors authorizes a $1 billion share repurchase program GE HealthCare (NASDAQ:GEHC) today reported financial results for the first quarter ended March 31, 2025. GE He

      4/30/25 6:20:00 AM ET
      $GEHC
      Medical Electronics
      Health Care

    $GEHC
    Financials

    Live finance-specific insights

    See more
    • GE HealthCare reports first quarter 2025 financial results

      Revenue growth was 3% year-over-year; Organic revenue growth* was 4% Net income margin was 11.8% versus 8.0% for the prior year; Adjusted earnings before interest and taxes (EBIT) margin* was 15.0% versus 14.7% Diluted earnings per share (EPS) were $1.23 versus $0.81 for the prior year; Adjusted EPS* was $1.01 versus $0.90 Cash flow from operating activities was $250 million versus $419 million for the prior year; Free cash flow* was $98 million versus $274 million Updates full-year 2025 guidance Board of Directors authorizes a $1 billion share repurchase program GE HealthCare (NASDAQ:GEHC) today reported financial results for the first quarter ended March 31, 2025. GE He

      4/30/25 6:20:00 AM ET
      $GEHC
      Medical Electronics
      Health Care
    • GE HealthCare to announce first quarter 2025 results on April 30, 2025

      GE HealthCare (NASDAQ:GEHC) will announce its first quarter 2025 financial results before the market opens on Wednesday, April 30, 2025. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay also will be posted at the same link on the GE HealthCare Investor Relations website. About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical techno

      4/17/25 4:01:00 PM ET
      $GEHC
      Medical Electronics
      Health Care
    • GE HealthCare announces cash dividend for first quarter of 2025

      The Board of Directors of GE HealthCare Technologies Inc. (NASDAQ:GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the first quarter of 2025 payable on May 15, 2025 to all shareholders of record as of April 25, 2025. About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than

      3/27/25 11:34:00 AM ET
      $GEHC
      Medical Electronics
      Health Care

    $GEHC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Jimenez Frank R bought $100,624 worth of shares (1,315 units at $76.52), increasing direct ownership by 2% to 75,796 units (SEC Form 4)

      4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)

      5/2/24 6:00:38 AM ET
      $GEHC
      Medical Electronics
      Health Care

    $GEHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: Chief Technology Officer Kass-Hout Taha covered exercise/tax liability with 8,547 shares, decreasing direct ownership by 13% to 56,280 units (SEC Form 4)

      4/A - GE HealthCare Technologies Inc. (0001932393) (Issuer)

      5/7/25 4:11:06 PM ET
      $GEHC
      Medical Electronics
      Health Care
    • SEC Form 3 filed by new insider Bankes Jeannette

      3 - GE HealthCare Technologies Inc. (0001932393) (Issuer)

      5/1/25 4:06:35 PM ET
      $GEHC
      Medical Electronics
      Health Care
    • Chief Accounting Officer Newcomb George A. covered exercise/tax liability with 342 shares and was granted 1,156 shares, increasing direct ownership by 12% to 7,705 units (SEC Form 4)

      4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)

      3/5/25 7:47:57 PM ET
      $GEHC
      Medical Electronics
      Health Care

    $GEHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • GE HealthCare upgraded by UBS with a new price target

      UBS upgraded GE HealthCare from Sell to Neutral and set a new price target of $73.00

      5/5/25 8:34:55 AM ET
      $GEHC
      Medical Electronics
      Health Care
    • GE HealthCare upgraded by Goldman with a new price target

      Goldman upgraded GE HealthCare from Neutral to Buy and set a new price target of $100.00 from $85.00 previously

      3/11/25 7:35:30 AM ET
      $GEHC
      Medical Electronics
      Health Care
    • GE HealthCare upgraded by Jefferies with a new price target

      Jefferies upgraded GE HealthCare from Hold to Buy and set a new price target of $103.00 from $95.00 previously

      1/8/25 7:50:38 AM ET
      $GEHC
      Medical Electronics
      Health Care

    $GEHC
    Leadership Updates

    Live Leadership Updates

    See more
    • GE HealthCare names Jeannette Bankes president and CEO, Patient Care Solutions

      GE HealthCare (NASDAQ:GEHC), a leading global healthcare solutions provider, announced the appointment of Jeannette Bankes as president and CEO, Patient Care Solutions, effective May 1, 2025. Peter Arduini, president and CEO, GE HealthCare, said, "Jeannette is a proven leader who has diverse and deep experience at publicly traded companies in the healthcare industry. We proudly welcome her to the company and are confident that she has the expertise to move Patient Care Solutions forward and deliver on our precision care strategy." Bankes brings with her three decades of global experience including product management, marketing, sales, regulatory, medical affairs, and operations and manufa

      4/9/25 9:00:00 AM ET
      $GEHC
      Medical Electronics
      Health Care
    • GE HealthCare's MIM Software collaborates with Elekta to help enhance radiation therapy treatments and improve patient outcomes

      Collaboration has always been important in the healthcare industry, but in this era of digital health, teamwork across institutions has become essential Enhancing Elekta's radiation therapy offerings with GE HealthCare's MIM Software medical imaging management solutions will help drive greater benefits for global healthcare systems This new collaboration complements GE HealthCare and Elekta's existing global commercial collaboration agreement, which enables the two companies to provide hospitals and cancer patients a comprehensive radiation therapy offering across imaging and treatment Weeks after closing its acquisition of MIM Software – a global provider of medical imaging analy

      4/22/24 7:07:00 AM ET
      $GEHC
      Medical Electronics
      Health Care

    $GEHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by GE HealthCare Technologies Inc.

      SC 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

      11/12/24 12:53:28 PM ET
      $GEHC
      Medical Electronics
      Health Care
    • Amendment: SEC Form SC 13G/A filed by GE HealthCare Technologies Inc.

      SC 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

      10/22/24 4:16:16 PM ET
      $GEHC
      Medical Electronics
      Health Care
    • SEC Form SC 13G/A filed by GE HealthCare Technologies Inc. (Amendment)

      SC 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

      4/2/24 4:07:29 PM ET
      $GEHC
      Medical Electronics
      Health Care

    $GEHC
    SEC Filings

    See more
    • SEC Form 10-Q filed by GE HealthCare Technologies Inc.

      10-Q - GE HealthCare Technologies Inc. (0001932393) (Filer)

      4/30/25 6:26:15 AM ET
      $GEHC
      Medical Electronics
      Health Care
    • GE HealthCare Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

      8-K - GE HealthCare Technologies Inc. (0001932393) (Filer)

      4/30/25 6:25:29 AM ET
      $GEHC
      Medical Electronics
      Health Care
    • SEC Form DEFA14A filed by GE HealthCare Technologies Inc.

      DEFA14A - GE HealthCare Technologies Inc. (0001932393) (Filer)

      4/10/25 7:20:11 AM ET
      $GEHC
      Medical Electronics
      Health Care